Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Gene Walther

CEO of Vortex BioSciences

Gene Walther is a senior executive with over 20 years of experience in the for-profit and global health segments focusing on diagnostics, medical devices and biotechnology. Gene is currently consulting to the Paul G. Allen Family Foundation on their Ebola Strategy with a particular focus on the role of diagnostics. Most recently, Gene worked at the Bill & Melinda Gates Foundation as the Deputy Director of Diagnostics. Prior to joining the Gates Foundation, Gene worked in a number of for-profit companies including the venture capital industry where he served as Executive Chairman for GenturaDx.

Mr. Walther was President of Chiron’s Blood Testing Division prior to the acquisition by Novartis in 2006 and then President of Novartis Diagnostics. Prior to joining Chiron/Novartis Mr. Walther was Vice President of Sales & Marketing for Gen-Probe, and various positions at Abbott Diagnostics Division and American Hospital Supply Corporation (later acquired by Baxter).

Mr. Walther earned a BS degree in immunology and microbiology from Michigan State University and a MBA from the Foster School of Business at the University of Washington.

Gene Walther - NetScientific